Finnrick - Ensuring a Safer and More Transparent Supply Chain
M-Peptides

M-Peptides
Tirzepatide

Finnrick tested 4 samples of Tirzepatide (GLP-1 and GIP antagonist) from M-Peptides between 20 Jun 2025 and 25 Jul 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).

Finnrick Rating™
A
GREAT
Tentative Rating
M-Peptides
Tirzepatide
Tested 4 Samples
Last test 25 Jul 2025

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

All Tirzepatide tests from M-Peptides

Samples are tested in commercial labs

Tests Count

4

Scores

AVG7.8MIN6.3MAX8.8

Last

25 Jul 2025

First

20 Jun 2025
Quantity
Test DateCertificate
Test Score
Label
Batch
TestedDifferencePurityBatch IDContainerTested AtSent By
25 Jul 2025View8.330mg
32.9mg
30.100mg-8.4%99.85%2025M3P0S01-5MWhite Label / Silver Crimp / Pink CapLab EPublic
2 Jul 2025View6.350mg(no batch claim)48.600mg-2.8%99.16%(no batch ID)No Label / Silver Crimp / Yellow Cap Lab EPublic
20 Jun 2025View8.840mg(no batch claim)41.700mg+4.3%99.83%M4P0501No Label / Silver Crimp / Orange CapLab EPublic
20 Jun 2025View7.660mg(no batch claim)52.000mg-13.3%99.82%M6P0S01White Label / Silver Crimp / Yellow Cap Lab EPublic